Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abdul Monem Hamid

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Transplant International : Official Journal of the European Society for Organ Transplantation|March 15, 2018
Donor-specific HLA antibody-mediated complement activation is a significant indicator of antibody-mediated rejection and poor long-term graft outcome during lung transplantation: a single center cohort studyAntoine Roux, Kimberly A Thomas, Edouard Sage, et al.
Arthritis Research & Therapy|July 25, 2006
Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonistsHaïfa Hamdi, Xavier Mariette, Véronique Godot, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 12, 2015
High Emergency Lung Transplantation: dramatic decrease of waiting list death rate without relevant higher post-transplant mortalityAntoine Roux, Laurence Beaumont-Azuar, Abdul Monem Hamid, et al.
Frontiers in Medicine|October 28, 2017
Characteristics of Donor-Specific Antibodies Associated With Antibody-Mediated Rejection in Lung TransplantationAntoine Roux, Ines Bendib Le Lan, Sonia Holifanjaniaina, et al.
Lung Cancer (Amsterdam, Netherlands)|August 26, 2017
Lung cancer in renal transplant recipients: A case-control studyClaire Rousseau-Gazaniol, Séverine Fraboulet, Louis-Jean Couderc, et al.
Circulation|October 5, 2011
Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registryJoanna Pepke-Zaba, Marion Delcroix, Irene Lang, et al.
The Lancet. Rheumatology|January 24, 2024
The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statementsAnna-Maria Hoffmann-Vold, Toby M Maher, Edward E Philpot, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Transplant International : Official Journal of the European Society for Organ Transplantation|March 15, 2018
Donor-specific HLA antibody-mediated complement activation is a significant indicator of antibody-mediated rejection and poor long-term graft outcome during lung transplantation: a single center cohort studyAntoine Roux, Kimberly A Thomas, Edouard Sage, et al.
Arthritis Research & Therapy|July 25, 2006
Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonistsHaïfa Hamdi, Xavier Mariette, Véronique Godot, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 12, 2015
High Emergency Lung Transplantation: dramatic decrease of waiting list death rate without relevant higher post-transplant mortalityAntoine Roux, Laurence Beaumont-Azuar, Abdul Monem Hamid, et al.
Frontiers in Medicine|October 28, 2017
Characteristics of Donor-Specific Antibodies Associated With Antibody-Mediated Rejection in Lung TransplantationAntoine Roux, Ines Bendib Le Lan, Sonia Holifanjaniaina, et al.
Lung Cancer (Amsterdam, Netherlands)|August 26, 2017
Lung cancer in renal transplant recipients: A case-control studyClaire Rousseau-Gazaniol, Séverine Fraboulet, Louis-Jean Couderc, et al.
Circulation|October 5, 2011
Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registryJoanna Pepke-Zaba, Marion Delcroix, Irene Lang, et al.
The Lancet. Rheumatology|January 24, 2024
The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statementsAnna-Maria Hoffmann-Vold, Toby M Maher, Edward E Philpot, et al.
Pageof 1